Group One Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,100
Closed -$26.2K 8510
2023
Q2
$26.2K Sell
10,100
-6,500
-39% -$23.2K ﹤0.01% 5781
2023
Q1
$67.7K Buy
16,600
+14,900
+876% +$68.9K ﹤0.01% 4619
2022
Q4
$8.53K Sell
1,700
-3,200
-65% -$20.1K ﹤0.01% 6084
2022
Q3
$64K Buy
4,900
+4,700
+2,350% +$71.2K ﹤0.01% 5206
2022
Q2
$3K Buy
+200
New +$2.77K ﹤0.01% 7342
2022
Q1
Sell
-9,200
Closed -$163K 8932
2021
Q4
$163K Buy
9,200
+7,400
+411% +$142K ﹤0.01% 5287
2021
Q3
$38K Hold
1,800
﹤0.01% 6761
2021
Q2
$36K Buy
1,800
+1,600
+800% +$37.5K ﹤0.01% 6841
2021
Q1
$6K Buy
200
+100
+100% +$2.8K ﹤0.01% 7210
2020
Q4
$3K Sell
100
-200
-67% -$4.38K ﹤0.01% 6196
2020
Q3
$5K Sell
300
-200
-40% -$3.65K ﹤0.01% 5655
2020
Q2
$10K Buy
+500
New +$9.56K ﹤0.01% 5133

Group One Trading's NGM Position: Q2 2024 in Review

Group One Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 1,052 shares — an estimated $1.67K sold.

Group One Trading first reported a position in NGM in Q3 2020 and held it in 7 quarters. The position peaked at $56K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Group One Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 1,052 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.67K.
  • Group One Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Group One Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $56K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.